Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance - Test2 - elhamkhani - TriplyDB

Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance

Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance

http://www.wikidata.org/entity/Q33851157

about

Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma.Prognostic and clinicopathological significance of Gankyrin overexpression in cancers: evidence from a meta-analysis Gankyrin has an antioxidative role through the feedback regulation of Nrf2 in hepatocellular carcinoma.Gankyrin promotes epithelial-mesenchymal transition and metastasis in NSCLC through forming a closed circle with IL-6/ STAT3 and TGF-β/SMAD3 signaling pathway Gankyrin regulates cell signaling network.Gankyrin as a potential therapeutic target for cancer.Upregulation of PSMD10 caused by the JMJD2A histone demethylase.MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.

P2860

Q35775787-F96BB210-7889-4A0C-B035-4E36177FE598 Q35997896-763F0703-7AF3-4A0C-A19C-3CF55EEC1A65 Q36863127-80B95734-90FF-42CE-84C1-46E10C762302 Q37701508-A1710DBD-B98C-4C5D-8C71-5C9AA2CBD40C Q38714564-42C0E309-A0D2-4A97-8E1D-CEEA643082C8 Q39319386-2EF3CD2F-D78F-4667-A7D4-B6E28743F536 Q41615123-0E0497DC-1886-4875-BC59-455E253223B8 Q49796436-20309CC4-B061-42E4-90D0-E7BEA6D2BDB4

P2860

Gradually elevated expression of Gankyrin during human hepatocarcinogenesis and its clinicopathological significance

http://www.wikidata.org/entity/Q33851157

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Gradually elevated expression ...... inicopathological significance

@ast

Gradually elevated expression ...... inicopathological significance

@en

type

label

Gradually elevated expression ...... inicopathological significance

@ast

Gradually elevated expression ...... inicopathological significance

@en

prefLabel

Gradually elevated expression ...... inicopathological significance

@ast

Gradually elevated expression ...... inicopathological significance

@en

P1433

Q33851157-FF3F8603-FF7D-4E32-A6FD-06ACED38C1FB

P1476

Q33851157-9E51BD5B-55D6-40B9-81CE-7D86D13EA9A0

P2093

Q33851157-11AD5AA7-E07E-47AC-B199-2EE2C6067581

Q33851157-79CA7CEA-2D56-4236-A72D-E32452F23827

Q33851157-8BA84237-FB33-45C1-B41B-00E425096109

Q33851157-9BD307B0-D2A6-4246-8650-CE6140663FA3

Q33851157-B2D03D11-1A67-4DC5-9E77-9A57FA4C0077

Q33851157-DCB083AB-365C-47B5-9B0C-3C4A36A02345

P2860

Q33851157-0583E6FE-CA82-4571-9B61-1ECBB77E6145

Q33851157-098FE706-4AAD-4058-8987-30458EDEC079

Q33851157-1392B14B-358E-4EC3-8A3A-CD30AD70CA1F

Q33851157-1A7F6CD7-E31F-48B4-8561-1A2771F44059

Q33851157-29DA20B3-F7AF-4A8B-A5CD-FF37765618B5

Q33851157-2CEB9531-6DCC-4251-8C9B-E74D9248714D

Q33851157-2D3C76A0-FCCA-4C79-B94E-AFDB09D3F452

Q33851157-34790949-63F1-49C1-A456-0DB7828DE3CD

Q33851157-3BD317B7-CCE0-4AE4-9B87-15251E26A157

Q33851157-3F83BCFD-5177-42A4-A0C7-8ED75320F3CF

P2888

Q33851157-E40030C9-3775-4302-BE3C-4D915FCDC17F

P304

Q33851157-625B85F2-A7A9-4F58-87AE-3C5089391595

P31

Q33851157-CFC3EA7E-B27B-4D57-AE96-4DD591C8CEDD

P356

Q33851157-C46069FE-D7AC-43C9-B12E-55A100C67C56

P407

Q33851157-DF1D3793-9B26-4C63-B450-84BCEE19E572

P478

Q33851157-E7C5BC7D-6B79-468A-BEAA-4C69A92A9AF6

P577

Q33851157-EDF0190B-2BA7-46C0-AFC9-875840F6A47D

P5875

Q33851157-8C18C391-0C2C-4E0C-9427-A823A8446167

P6179

Q33851157-627E712E-F7B9-4909-BFBC-2FBE8016A4B2

P698

Q33851157-74537D74-0F12-4A96-8BE3-3CD225503077

P932

Q33851157-6160F22B-E8C5-42C8-B373-940AA7DA441E

P356

P1433

Scientific Reports

P1476

Gradually elevated expression ...... inicopathological significance

@en

P2093

Guoming Zhang

http://www.w3.org/2001/XMLSchema#string

Haiying Mo

http://www.w3.org/2001/XMLSchema#string

Hongbiao Jing

http://www.w3.org/2001/XMLSchema#string

Lingsheng Meng

http://www.w3.org/2001/XMLSchema#string

Qingda Meng

http://www.w3.org/2001/XMLSchema#string

Yanhong Tai

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas

Global cancer statistics

Novel insights into the INK4-CDK4/6-Rb pathway: counter action of gankyrin against INK4 proteins regulates the CDK4-mediated phosphorylation of Rb

The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53

The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53

Tumour invasion and metastasis initiated by microRNA-10b in breast cancer

Genetic aspects of hepatocellular carcinogenesis.

To cycle or not to cycle: a critical decision in cancer.

The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation.

Overexpression of p28/gankyrin in human hepatocellular carcinoma and its clinical significance

P2888

P304

5503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP05503

http://www.w3.org/2001/XMLSchema#string

P407

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263740805

http://www.w3.org/2001/XMLSchema#string

P6179

1035610686

http://www.w3.org/2001/XMLSchema#string

P698

24999092

http://www.w3.org/2001/XMLSchema#string

P932

4083285

http://www.w3.org/2001/XMLSchema#string